Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2012 1
2013 1
2015 1
2016 1
2017 2
2018 1
2019 1
2020 2
2021 5
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nicoletti nagy (3 results)?
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi M, Nagy N, Reis H, Hadaschik B, Niedworok C, Modos O, Szendroi A, Ablat J, Black PC, Keresztes D, Csizmarik A, Olah C, Gaisa NT, Kiss A, Timar J, Toth E, Csernak E, Gerstner A, Mittal V, Karkampouna S, Kruithof de Julio M, Gyorffy B, Bedics G, Rink M, Fisch M, Nyirady P, Szarvas T. Varadi M, et al. Among authors: nagy n. Cancer Med. 2023 Apr;12(7):9041-9054. doi: 10.1002/cam4.5639. Epub 2023 Jan 20. Cancer Med. 2023. PMID: 36670542 Free PMC article.
Discovery of two new isoforms of the human DUT gene.
Rácz GA, Nagy N, Várady G, Tóvári J, Apáti Á, Vértessy BG. Rácz GA, et al. Among authors: nagy n. Sci Rep. 2023 May 12;13(1):7760. doi: 10.1038/s41598-023-32970-1. Sci Rep. 2023. PMID: 37173337 Free PMC article.
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H, van der Vos KE, Niedworok C, Herold T, Módos O, Szendrői A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, Ablat J, Okon K, Tolkach Y, Keresztes D, Nagy N, Bremmer F, Gaisa NT, Chlosta P, Kriegsmann J, Kovalszky I, Timar J, Kristiansen G, Radzun HJ, Knüchel R, Schuler M, Black PC, Rübben H, Hadaschik BA, Schmid KW, van Rhijn BWG, Nyirády P, Szarvas T. Reis H, et al. Among authors: nagy n. Int J Cancer. 2018 Oct 1;143(7):1764-1773. doi: 10.1002/ijc.31547. Epub 2018 May 10. Int J Cancer. 2018. PMID: 29672836 Free article.
Prevalence of APC and PTEN Alterations in Urachal Cancer.
Nagy N, Reis H, Hadaschik B, Niedworok C, Módos O, Szendrői A, Bíró K, Hager T, Herold T, Ablat J, Black PC, Okon K, Tolkach Y, Csizmarik A, Oláh C, Keresztes D, Bremmer F, Gaisa NT, Kriegsmann J, Kovalszky I, Kiss A, Tímár J, Szász MA, Rink M, Fisch M, Nyirády P, Szarvas T. Nagy N, et al. Pathol Oncol Res. 2020 Oct;26(4):2773-2781. doi: 10.1007/s12253-020-00872-6. Epub 2020 Aug 4. Pathol Oncol Res. 2020. PMID: 32754865 Free PMC article.
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
Keresztes D, Csizmarik A, Nagy N, Módos O, Fazekas T, Bracht T, Sitek B, Witzke K, Puhr M, Sevcenco S, Kramer G, Shariat S, Küronya Z, Takács L, Tornyi I, Lázár J, Hadaschik B, Lászik A, Szűcs M, Nyirády P, Szarvas T. Keresztes D, et al. Among authors: nagy n. J Cell Mol Med. 2022 Feb;26(4):1332-1337. doi: 10.1111/jcmm.17141. Epub 2021 Dec 30. J Cell Mol Med. 2022. PMID: 34970839 Free PMC article.
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.
Csizmarik A, Keresztes D, Nagy N, Bracht T, Sitek B, Witzke K, Puhr M, Tornyi I, Lázár J, Takács L, Kramer G, Sevcenco S, Maj-Hes A, Jurányi Z, Hadaschik B, Nyirády P, Szarvas T. Csizmarik A, et al. Among authors: nagy n. Int J Cancer. 2022 Oct 15;151(8):1405-1419. doi: 10.1002/ijc.34159. Epub 2022 Jun 21. Int J Cancer. 2022. PMID: 35689436 Free PMC article.
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genes.
Olah C, Hahnen C, Nagy N, Musial J, Varadi M, Nyiro G, Gyorffy B, Hadaschik B, Rawitzer J, Ting S, Sjödahl G, Hoffmann MJ, Reis H, Szarvas T. Olah C, et al. Among authors: nagy n. Int J Cancer. 2022 Mar 1;150(5):856-867. doi: 10.1002/ijc.33809. Epub 2021 Oct 2. Int J Cancer. 2022. PMID: 34536301 Free article.
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.
Csizmarik A, Nagy N, Keresztes D, Váradi M, Bracht T, Sitek B, Witzke K, Puhr M, Tornyi I, Lázár J, Takács L, Kramer G, Sevcenco S, Maj-Hes A, Hadaschik B, Nyirády P, Szarvas T. Csizmarik A, et al. Among authors: nagy n. Prostate Cancer Prostatic Dis. 2023 Aug 26. doi: 10.1038/s41391-023-00713-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37634036
23 results